Qui sommes-nous ? About us
L'ANSM en bref
About us
Nos engagements
Nos missions
Notre périmètre
Notre organisation
Déontologie et transparence
Publications institutionnelles
Publications scientifiques
Rejoignez-nous !
Notre agenda
 
Actualités
Nos articles
Nos campagnes
 
Bulletin officiel des actes, décisions et avis
Décisions institutionnelles
Décisions liées aux médicaments
Décisions liées aux produits sanguins et autres produits biologiques
Décisions liées aux médicaments dérivés du plasma
Décisions liées aux dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
Injonctions
Décisions de police sanitaire
Sanctions financières
Avis
 
Disponibilité des produits de santé
Médicaments
Dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
 
Vos démarches
Industriel
Organismes notifiés
Professionnel de santé
Patient
Chercheur

Our scope of action

A+ A-
> Consultez la version française

As health products, medical devices and in vitro diagnostic devices fall within ANSM’s scope of action. As part of its market surveillance remit, ANSM ensures that all of these devices available in France are safe, effective, and properly used. As such, it authorises clinical trials, inspects economic operators’ sites, checks the conformity of marketed devices, facilitates innovation, helps construct European regulations on medical and in vitro diagnostic devices, provides individuals or stakeholders who send queries with information and explanations, or guides them in their research.
 

Medical devices and in vitro diagnostic medical devices (IVDMDs)

Medical devices

medical device is any instrument, apparatus, equipment, material or product (except products of human origin), including accessories and software, that is used alone or in combination, for medical purposes in humans, and which does not achieve its principal intended action by pharmacological, immunological or metabolic means.

The medical device market is extremely vast and the sector is highly innovative. The industrial network is multiple and diversified; it includes both large multinational groups and small and medium-sized enterprises.
It includes over 20,000 types of products, ranging from single-use or reusable consumables (dressings, compresses, etc.), to implants (breast prostheses, pacemakers, etc.), also including equipment (medical beds, etc.).

Different medical device classes

Medical devices are classified according to level of risk associated with their use (duration of use, exposed part of the body, inside or outside the body), and the potential risks associated with their use for public health (class I to III).
These risk classes hence also express the expected medical benefit for the patient.
  • Class I (lowest risk class): e.g. compresses, spectacles, crutches, etc.;
  • Class IIa (moderate/modest potential risk): e.g. contact lenses, ultrasound devices, dental crowns, etc.;
  • Class IIb (high/significant potential risk): e.g. condoms, lens disinfection products, etc.;
  • Class III (highest risk class): e.g. breast implants, stents, hip prostheses, etc.
Manufacturers are responsible for the classification of an MD, depending on the claimed end use of the device. For this, they use the rules set out in European regulations as a basis.

In vitro diagnostic medical devices

An in vitro diagnostic medical device is a product or instrument, including accessories and software, intended by its manufacturer to be used in vitro in the examination of samples of human origin (blood, urine, tissues, etc.), for the purpose of providing information, particular about an individual’s physiological or pathological state or about a congenital anomaly.
Tests (COVID-19 test, pregnancy test, blood glucose assay test, etc.), also known as “reagents”, used in laboratories to conduct pathology tests particularly fall within this category.

Different in vitro diagnostic medical device categories

Regulation (EU) 2017/746 identifies several IVDMD categories.
This prescriptive classification defines “lists” (A and B) including IVDMDs having a high risk for patients and for public health. Depending on whether they are included in these lists or not, the IVDMDs in question are not subject to the same conformity requirements.
The directive also makes a distinction between devices for self-diagnosis and IVDMDs for assessing performances, and IVDMDs which do not fall under List A, List B, or self-diagnosis.